Related by context. All words. (Click for frequent words.) 69 APOE genotype 67 HIV HCV coinfected 66 angiographically 66 ADPKD 66 artery stenosis 66 Subgroup analyzes 66 histological subtype 66 hematopoietic cancers 66 prostate cancer CaP 66 HER2 expression 65 transient elastography 65 CP CPPS 65 LVNC 65 K ras mutation 65 stratifying patients 65 genetic polymorphisms 65 tumor histology 65 ASCUS 65 GBA mutations 65 monoclonal gammopathy 65 clinicopathological 65 laterality 65 pathophysiological mechanisms 65 Chronic pancreatitis 64 underlying pathophysiology 64 familial clustering 64 urothelial cancer 64 CYP#D# genotype 64 autonomic dysfunction 64 gadolinium enhanced 64 hematological parameters 64 Logistic regression 64 differential gene expression 64 intact parathyroid hormone 64 KRAS status 64 hippocampal atrophy 64 biochemical abnormalities 64 #F FDG PET 64 motor neuron degeneration 64 carotid plaques 64 metabolite concentrations 64 CTEPH 63 prostate cancer PCa 63 Genetic variants 63 Tasigna prolongs 63 prognostic indicators 63 prognostic significance 63 gastric cardia 63 hyperacute 63 germline mutations 63 intraobserver 63 choroidal vasculopathy 63 liver metastasis 63 Prognostic factors 63 urolithiasis 63 genetic locus 63 serum aminotransferase levels 63 choroidal neovascularization 63 nonalcoholic steatohepatitis NASH 63 amyloid deposition 63 VKORC1 63 urothelial carcinoma 63 subclinical atherosclerosis 63 troponins 63 Logistic regression analysis 63 histopathological 63 FDG PET scans 63 chromosomal mutations 63 spontaneous regression 63 diabetic kidney 63 Subgroup analysis 63 electrophysiologic 63 LRRK2 mutations 63 genomic biomarker 63 cortical atrophy 63 logistic regression analysis 63 amnestic MCI 63 NMIBC 63 pelvic lymphadenectomy 63 Multiple logistic regression 63 K ras mutations 62 PCNSL 62 hepatic fibrosis 62 Cognitive impairment 62 HER2 positivity 62 ovarian malignancy 62 Non inferiority 62 mutated K ras 62 histopathologic examination 62 primary aldosteronism 62 liver transplant recipients 62 histologic subtype 62 Histologic 62 Coronary artery calcium 62 atherothrombotic 62 spirometric 62 Orthostatic hypotension 62 Colon polyps 62 presymptomatic 62 SCr 62 SSc 62 unmeasured confounders 62 tissue oxygenation 62 univariate analyzes 62 plasma pharmacokinetics 62 multifactorial disease 62 p# biomarker 62 microsatellite instability 62 acute aortic dissection 62 intracerebral 62 proton MR spectroscopy 62 silent myocardial ischemia 62 Histological 62 aMCI precursor 62 renal cysts 62 prognostic marker 62 moderately heritable 62 euthymic patients 62 cranial irradiation 62 conditional logistic regression 62 abdominal adiposity 62 Genetic variation 62 seminomas 62 prospective multicenter study 62 KRAS mutation 62 DNA methylation patterns 62 supratentorial 62 perfusion defects 61 clinically insignificant 61 premorbid 61 neovascular 61 dosimetric 61 monogenic 61 cytologic 61 Uncontrolled hypertension 61 Randomized trials 61 heterozygotes 61 florbetaben 61 Epidemiologic studies 61 LV dysfunction 61 gene polymorphism 61 aminotransferase 61 Prostate specific antigen 61 Multivariate analyzes 61 chemosensitivity 61 genomic alterations 61 pre malignant lesions 61 somatic mutations 61 myocardial viability 61 radiographic findings 61 HRCT 61 morphologic 61 BRAF V#E 61 neuropathologic 61 NP CRNs 61 FDG-PET/CT 61 nodal metastasis 61 clinicopathological features 61 serum markers 61 lesional 61 Diabetic nephropathy 61 renal artery stenosis 61 mucinous 61 Sjögren syndrome 61 thyroid nodules 61 Endothelial dysfunction 61 percutaneous biopsy 61 NAbs 61 corneal thickness 61 neurocognitive dysfunction 61 Cardiotoxicity 61 histopathologic diagnosis 61 dysglycemia 61 neurocognitive deficits 61 lactate dehydrogenase LDH 61 Multivariate analysis 61 nonmetastatic 61 Chlamydia psittaci 61 EBV infection 61 glomerular filtration 61 Parkinson Disease PD 61 Hypotension 61 ABL1 61 comorbid anxiety 61 Hp2 2 61 renal carcinoma 61 EGFR mutation status 61 differentially expressed genes 61 arterial thickening 61 riociguat 61 surrogate markers 61 completely resected 61 tau protein tangles 61 genetic polymorphism 61 serum biomarkers 61 microvessel 61 echocardiographic parameters 61 metaplasia 61 hypometabolism 61 obstructive coronary 61 sensitivity specificity 61 periprocedural MI 61 susceptibility loci 61 Hurthle cell 61 allogeneic HSCT 61 impaired insulin secretion 61 bronchopulmonary dysplasia BPD 61 prostate carcinoma 61 subclinical hyperthyroidism 61 PCa 61 Univariate analysis 61 autoregulation 61 perfusion MRI 61 levodopa induced 61 hamartomas 61 prognostic variables 61 APOE e4 61 Lymph node 61 MSMB 61 Prostatitis 61 immunohistochemical analysis 61 thyrotropin 61 d dimer 61 carotid plaque 61 Subarachnoid hemorrhage 61 left ventricular diastolic 61 acetabular fractures 61 recurrent glioblastoma multiforme 61 cardiac repolarization 61 Multivariate logistic regression 61 nonischemic 61 colorectal adenocarcinoma 61 PITX2 methylation 61 debilitating neurodegenerative disorder 60 hematologic parameters 60 transfusion syndrome 60 multi infarct dementia 60 neuritic 60 etiologic 60 pretreatment serum 60 psychosocial variables 60 carotid stenosis 60 hypermethylated 60 hormone receptor status 60 HER2 overexpression 60 neurosensory 60 CD# expression [002] 60 QRS interval 60 GH deficiency 60 elevated IOP 60 F FDG PET 60 bacteriuria 60 diabetes mellitus DM 60 methylation patterns 60 ABCB1 60 gene rearrangements 60 multiple logistic regression 60 bronchial hyperresponsiveness 60 prognostic biomarker 60 specific antigen PSA 60 thyroid carcinoma 60 proliferative retinopathy 60 multivariate logistic regression 60 neurocognitive impairment 60 System IPSS 60 serum BDNF 60 chest radiographs 60 multivessel coronary artery 60 Diabetic neuropathy 60 genetic loci 60 prostate carcinogenesis 60 HNSCC 60 nephrogenic 60 malignant nodules 60 Cystatin C 60 syndromal 60 MGUS 60 pathophysiologic 60 transrectal ultrasound guided 60 syndromic 60 autopsied brains 60 hippocampal function 60 hepatorenal syndrome 60 renal allograft 60 HeFH 60 circulating endothelial cells 60 Opportunistic infections 60 leiomyomas 60 neurocognitive function 60 logistic regression analyzes 60 colorectal carcinoma 60 symptomatic VTE 60 IPAH 60 poststroke depression 60 sCJD 60 hypoperfusion 60 transvaginal sonography 60 bivariate analysis 60 squamous cell lung cancer 60 lung nodule 60 cervical lymph nodes 60 neurologic symptoms 60 silent ischemia 60 primary hyperparathyroidism 60 dopaminergic therapy 60 cerebral atrophy 60 plasma kallikrein 60 ADAGIO study 60 modifier genes 60 abnormal cytology 60 Safinamide 60 immunohistochemical 60 de novo mutations 60 serum lipids 60 microalbuminuria 60 PLX STROKE targeting 60 SOD2 gene 60 bone scintigraphy 60 KRAS mutations 60 pathologic diagnosis 60 KRAS mutation status 60 AST ALT 60 scintigraphic 60 CYP#C# genotype 60 dyssynchrony 60 cardiac dysfunction 60 chromosomal rearrangement 60 NPM1 mutation 60 clinicopathologic 60 gastric carcinoma 60 posttransplant 60 cerebral microbleeds 60 Proteinuria 60 cTnI 60 Heavy menstrual bleeding 60 carcinoids 60 clinico pathological 60 hyperuricaemia 60 oncologic outcomes 60 gastro esophageal reflux 60 prognostic markers 60 Genetic predisposition 60 imatinib resistance 60 gene polymorphisms 60 nonmelanoma skin cancers 60 anterior uveitis 60 pT2 60 poor metabolizers 60 allele frequencies 60 biochemical recurrence 60 histopathologic findings 60 obstructive coronary artery 60 intracerebral haemorrhage 60 Cardiorespiratory fitness 60 Haptoglobin 60 vasogenic edema 60 malignant neoplasm 60 cardiac troponin 60 renal biopsy 60 Radical prostatectomy 60 arteriography 60 miRNA expression 60 unmeasured factors 60 causative mutations 60 Genetic mutation 60 serum lipid levels 60 interobserver 60 colorectal adenoma 60 genomewide 60 bladder carcinoma 60 parkinsonian 60 myocardial infarct size 60 airway hyperresponsiveness 60 hemodynamic variables 60 breast cancer metastasis 60 neuropsychiatric symptoms 60 intracranial atherosclerosis 60 diabetic polyneuropathy 60 tumor subtype 60 lethal arrhythmias 60 ImmuKnow assay 60 carotid atherosclerosis 60 ConclusionThis 59 antiphospholipid syndrome 59 contrast echocardiography 59 MMSE score 59 pancreatic adenocarcinoma 59 cerebral oxygenation 59 SLNB 59 hepatic lesions 59 histologic subtypes 59 STRIDE PD 59 CT perfusion 59 serum urate levels 59 demyelinating 59 neovascularisation 59 bacterial prostatitis 59 extramedullary 59 abnormal glucose metabolism 59 nerve degeneration 59 subsyndromal 59 Unstable angina 59 multivariable adjusted 59 Computed tomography 59 postoperative complication 59 breast carcinomas 59 ischemic lesions 59 myopathies 59 gene locus 59 T2D 59 seminoma 59 TPMT 59 Main Outcome Measure 59 phenotypic expression 59 fundus photography 59 aortic stiffness 59 leukoencephalopathy 59 tumor subtypes 59 neoplasias 59 cardiac conduction 59 intraventricular 59 multivariate Cox 59 alexithymia 59 histologic findings 59 interobserver reliability 59 MR spectroscopy 59 p# activation 59 arthrography 59 erythema nodosum 59 hyperplastic 59 Electroencephalography 59 Longitudinal studies 59 CC genotype 59 aminotransferases 59 plain radiographs 59 S. maltophilia 59 aneuploidies 59 immunocompetent 59 Chronic lymphocytic leukemia 59 adnexal mass 59 advanced neoplasia 59 MSH2 59 chronic thromboembolic pulmonary 59 prognostically 59 subclinical disease 59 immunoblot 59 elevated triglyceride levels 59 Mild cognitive impairment 59 interobserver agreement 59 confounder 59 T2DM 59 lichen planus 59 thyroglobulin 59 relapsed MM 59 thrombotic complications 59 lymph node metastasis 59 variant angina 59 FDG PET 59 precursor lesions 59 soluble CD# ligand 59 Familial hypercholesterolemia 59 metastatic neuroendocrine tumors 59 HOMA IR 59 Papillary 59 GRNCM1 59 putative biomarkers 59 comorbid depression 59 inflammatory biomarkers 59 QTc prolongation 59 breast endometrial 59 BRCA2 mutation carriers 59 NNT = 59 CIN3 59 Magnesium deficiency 59 pulmonary nodules 59 aggregated Abeta 59 prodromal 59 perioperative complications 59 predisposing factor 59 metastatic lymph nodes 59 Medullary thyroid cancer 59 transcranial Doppler ultrasound 59 CIN2 + 59 rs# [004] 59 chromosomal aberrations 59 amyloid cascade 59 prognostic indicator 59 antioxidant supplementation 59 incidentalomas 59 thymoma 59 tumorigenicity 59 ADVEXIN therapy 59 transcranial Doppler 59 colonoscopic 59 Barrett esophagus BE 59 endoscopic ultrasonography 59 Singh Manoux 59 DHEA supplementation 59 pretest probability 59 HIV coinfected 59 metabolomic profiles 59 splenic 59 generalized epilepsy 59 endocrinologic 59 pharmacodynamic parameters 59 ultrasonographic examination 59 testicular tumors 59 gastric adenocarcinoma 59 prospectively defined 59 arterial calcification 59 Leydig cell 59 epithelial barrier 59 histologic 59 ductal adenocarcinoma 59 Lewy bodies DLB 59 Viral load 59 cystoscopic 59 pathologic fractures 59 RE LY trial 59 white matter hyperintensities 59 ultrasonographic 59 surgically resectable 59 microalbumin 59 undergo prostate biopsy 59 Rectal cancer 59 Critical Limb Ischemia CLI 59 Ischemic 59 thromboembolic disease 59 #q# deletion 59 Adjuvant therapy 59 chromosomal alterations 59 intima media thickness 59 pharmacokinetic characteristics 59 intra abdominal abscess 59 bony metastases 59 murine models 59 Sentinel node biopsy 59 serum GGT 59 postoperative AF 59 prospective multicentre 59 inhibin B 59 empiric treatment 59 TMPRSS2 ERG fusion 59 arterial oxygen saturation 59 residual confounding 59 adrenocortical 59 esophageal squamous cell carcinoma 59 Genetic variations 59 esophageal reflux 59 SRBD 59 serum biomarker 59 logistic regression model 59 HIV tropism 59 albumin excretion 59 biochemical markers 59 aminotransferase levels 59 Irregular heartbeat 59 noncardiac 59 pancreatic endocrine 59 TP# mutation 59 OSAHS 59 vascular endothelial dysfunction 59 Brugada syndrome 59 myocardial ischaemia 59 apolipoprotein E gene 59 Descriptive statistics 59 H. pylori infections 59 TOP2A 59 compulsive hoarding syndrome 59 haematuria 59 Leukemias 59 HSV1 59 BEXXAR Therapeutic Regimen 59 pulmonary hypertension PH 59 limiting generalizability 59 hyperactivation 59 cerebral perfusion 59 ADAMTS# 59 comorbid disorders 58 semiquantitative 58 pancreatic carcinoma 58 neuropsychological impairments 58 RQ PCR 58 Fibromyalgia Impact Questionnaire 58 thromboembolic complications 58 neurologic complications 58 interindividual variability 58 penetrance 58 systemic amyloidosis 58 transgenic mice expressing 58 precancerous condition 58 progressive neurodegenerative disorder 58 oral squamous cell 58 PsA 58 SLC#A# [002] 58 hematological relapse 58 ATG#L# 58 femoral neck fracture 58 postoperative pulmonary 58 PNH patients 58 histopathologic 58 postoperative morbidity 58 ptau 58 nodal metastases 58 Kaplan Meier curve 58 Alzheimer Disease AD 58 CORE OM 58 Randomised controlled trials 58 functional neuroimaging 58 urine cytology 58 affective psychosis 58 bile acid metabolism 58 Mild Cognitive Impairment 58 K ras gene 58 idiopathic pulmonary 58 TCF#L# gene 58 mammographically 58 hyperalgesia 58 metaanalysis 58 cardioembolic stroke 58 LV hypertrophy 58 albumin excretion rate 58 preoperative PSA 58 cardiac troponin T 58 diagnose Alzheimer disease 58 alkalosis 58 antibody titer 58 carotid IMT 58 seropositivity 58 antiangiogenic agent 58 liver histology 58 Trandolapril 58 pharmacodynamic effects 58 recurrent glioma 58 antiphospholipid antibodies 58 ventricular myocardium 58 chronic hepatitis cirrhosis 58 pilocytic astrocytomas 58 adenomatous 58 gene loci 58 vasculopathy 58 perioperatively 58 Hypertrophic cardiomyopathy 58 diagnosing coronary artery 58 intravascular hemolysis 58 pathogenetic 58 urine dipstick 58 BRCA1 BRCA2 58 maturational 58 subthalamic 58 knee osteoarthritis OA 58 thyrotropin levels 58 meta regression 58 oral anticoagulation 58 Polycythemia vera 58 KCNH2 58 cerebrospinal fluid CSF 58 thyroid deficiency 58 pleiotropic effects 58 carotid artery thickness 58 Brodmann Area 58 thyroid dysfunction 58 adrenalectomy 58 molecular biomarkers 58 genes differentially expressed 58 β blockers 58 Ribavirin causes 58 antiangiogenic therapy 58 multivariate analyzes 58 Multiple linear regression 58 nondemented 58 stem cell transplantations 58 hyperplastic polyps 58 procalcitonin 58 dose proportionality 58 Circulating tumor cells 58 antiplatelet therapies 58 inducible ischemia 58 rCBF 58 paraneoplastic 58 mononuclear cell 58 pseudogout 58 electron beam computed tomography 58 autosomal dominant polycystic kidney 58 Venous thromboembolism 58 PSA kinetics 58 bronchogenic carcinoma 58 paroxysmal nocturnal hemoglobinuria 58 dyskeratosis congenita 58 tissue perfusion 58 LRP5 58 pharmacogenetic tests 58 biologic pathways 58 clomipramine 58 experimentally induced 58 carcinoembryonic antigen 58 Epileptic seizures 58 T1a 58 genotype phenotype 58 pretransplant 58 embryonal 58 somatic mutation 58 ALB # 58 neurodevelopmental outcome 58 urate levels 58 core needle biopsies 58 prefrontal regions 58 polyomavirus nephropathy 58 CYP#D# gene 58 Computerized tomography 58 vascular reactivity 58 Chronic Lyme disease 58 minimally symptomatic 58 CaM kinase II 58 diffusion tensor 58 surgically resected 58 FDG PET imaging 58 adenomatous polyps 58 anterior temporal 58 schizotypal traits 58 paricalcitol 58 β amyloid 58 posterior cingulate 58 phenotypic characteristics 58 multiple linear regression 58 anti JCV antibodies 58 ventricular enlargement 58 atrophic 58 neuropathological 58 transesophageal echocardiography 58 coinfected patients 58 differentiate squamous 58 Obstructive sleep apnea OSA 58 perfusion abnormalities 58 LRRK2 mutation 58 pharmacodynamic markers 58 retrovirus XMRV 58 molecular abnormalities 58 lymphomas leukemias 58 rheumatic disorders 58 B7 H3 58 Helicobacter pylori infection 58 pancreatic ductal adenocarcinoma 58 Shortened telomeres 58 deCODE Glaucoma TM 58 cAMP signaling 58 malignant prostate 58 subclinical 58 orchitis 58 B streptococcal 58 undergoing coronary angiography 58 eNO 58 bronchoalveolar lavage BAL 58 pericardial effusion 58 covariate 58 endometrial biopsy 58 chlamydial infection 58 cerebral vasospasm 58 pulmonary metastasis 58 Chlamydia trachomatis infection 58 C1q 58 polycythemia vera PV 58 repolarization 58 phenotypic variation 58 endothelial activation 58 brain lesions 58 Coronary artery calcification 58 NHANES III 58 prolonged QT interval 58 HBeAg negative 58 INVEGA ® 58 aromatase inhibitors AIs 58 coinfection 58 neurologic deficits 58 paraganglioma 58 perilipin 58 hydroxy vitamin D 58 serum selenium 58 troponin T 58 invasive carcinoma 58 diagnose coronary artery 58 explanatory variables 58 BCR ABL mutations 58 perioperative morbidity 58 PD2i ® 58 chi squared 58 cryptogenic 58 pituitary adenomas 58 renal tumors 58 cardioprotective effects 58 SGPT 58 Heritability 58 da mage 58 PTPN# 58 recurrent laryngeal nerve 58 thyroid abnormalities 58 plasma fibrinogen 58 inverse agonist 58 Poisson regression 58 neuroregenerative 58 central corneal thickness 58 sleeve lobectomy 58 antiplatelet medications 58 KRAS oncogene 58 neuroimaging techniques 58 NSCLC tumors 58 logistic regression models 58 catheter angiography 58 sacral neuromodulation 58 histological examination 58 genes CYP#C# 58 calculi 58 vascular cognitive impairment 58 thromboembolic 58 LRAT 58 Chest x rays 58 computed tomographic scans 58 metabolic parameters 58 pleural fluid 58 diagnostic modality 58 genetic determinants 58 pathologic examination 58 proliferative diabetic retinopathy 58 Electrophysiological 58 PSADT 58 inflammatory demyelinating 58 predictive validity 58 duplex ultrasonography 58 cerebral infarction 58 DNA methylation markers 58 GABRA2 58 T1 weighted images 58 thoracic aortic aneurysm 58 postoperative delirium 58 androgen deficiency 58 FFR measurements 58 herpesviruses 58 radiolabeled TM# 58 FDG PET CT 58 Echocardiographic 58 colorectal cancer CRC 58 POAG 58 prenatal exposures 58 Ectopic pregnancy 58 myeloproliferative 58 hemoglobinopathies 58 histological diagnosis 58 hypogonadotropic hypogonadism 58 serum leptin 58 microRNA expression 58 Sporadic CJD 58 PROactive study 58 VaD 58 carcinomatosis 58 virological response 58 familial ALS 58 Fas ligand 58 immune reconstitution syndrome 58 ADCS CGIC 58 methylation markers 58 transgenic mouse models 58 Capsule endoscopy 58 physiological abnormalities 58 CD#c 58 coronary calcification 58 Acute Coronary 58 kinase inhibition 58 eTag assays 58 p tau 58 hemodynamically stable 58 biochemical marker 58 Adjuvant chemotherapy 58 stent stenosis 58 urine NGAL 58 cervical carcinoma 58 decompensated cirrhosis 58 ovarian carcinoma 58 Relapsing remitting MS 58 inherit predisposition 58 Hyperlipidemia 57 angiography CTA 57 postoperative mortality 57 nephrolithiasis 57 glomerular filtration rate 57 transabdominal 57 leptin deficiency 57 trait locus 57 skeletal metastases 57 ImmuKnow 57 ductal carcinomas 57 Meta analyzes 57 HbF 57 Tumor Response 57 mitochondrial toxicity 57 FGFR2 gene 57 radiochemotherapy 57 IDH mutations 57 multivariable analysis 57 acinar cells 57 kidney urologic 57 histological subtypes 57 atypical parkinsonism 57 Mathematical modeling 57 bone density measurements 57 waist circumference WC 57 CHEK2 57 immunochemical fecal occult 57 Observational studies 57 Immunohistochemical analysis 57 D Dimer 57 chromosomal anomalies 57 neurological manifestations 57 HORIZONS AMI trial 57 ALI ARDS 57 impaired glucose metabolism 57 Osteopenia 57 symptomology 57 Neurofibromatosis type 57 Coronary CTA 57 PSA nadir 57 coronary stenoses 57 activating mutation 57 TTR amyloidosis 57 etiologic factors 57 PrPSc 57 psychiatric comorbidity 57 aortic regurgitation 57 Preoperative 57 chemoresistant 57 Microalbuminuria 57 obstructive sleep 57 vascularisation 57 serum ferritin 57 pathological hallmark 57 TRAIL induced apoptosis 57 unresectable tumors 57 hemodynamic responses 57 neuro developmental disorders 57 RRM1 57 cortical thinning 57 Postoperative complications 57 leukocyte counts 57 genotypic resistance 57 antiarrhythmic medications 57 elevated fasting glucose 57 EGFR blockers 57 prodromal symptoms 57 susceptibility locus 57 mechanistic studies 57 Hypoglycaemia 57 antithrombotic therapy 57 survivin expression 57 malignant lesions 57 Optical coherence tomography 57 temporal arteritis 57 tryptophan depletion 57 cardiac magnetic resonance 57 apparent diffusion coefficient 57 paternally inherited 57 FGFs 57 transgene expression 57 intracranial stenosis 57 unruptured aneurysm 57 neuronal dysfunction 57 neuro degenerative disorders 57 Neurodegenerative diseases 57 SIADH 57 pheochromocytoma 57 NPHP 57 multisystem disease 57 EGFR inhibition 57 TNM staging 57 Telomere length 57 lactate dehydrogenase 57 endophenotypes 57 Single Nucleotide Polymorphisms SNPs 57 Hypertriglyceridemia 57 pharmacokinetic parameters 57 PITX2 57 sperm morphology 57 coagulation parameters 57 CDH1 57 papillary renal cell carcinoma 57 AGTR1 57 IgA deficiency 57 liver steatosis 57 postprocedure 57 normal karyotype 57 plasma lipoprotein 57 Lyme arthritis 57 haematologic 57 EEG abnormalities 57 anatomic abnormalities 57 acetabular dysplasia 57 thrombophilia 57 clinically detectable 57 neurological abnormalities 57 malignant lymphoma 57 International Prognostic Scoring